@article{ref1,
title="A cross-sectional study of treatments for behavioral disorders following traumatic brain injury: comparison with French recommendations",
journal="Journal of head trauma rehabilitation",
year="2019",
author="Bourseau, Tiphaine and Saout, Virginie and Ali, Pauline and Pouliquen-Loriferne, Uriell and Allain, Philippe and Dinomais, Mickaël",
volume="34",
number="4",
pages="E51-E60",
abstract="OBJECTIVE: To give a cross-sectional overview of ongoing management of behavioral disorders following traumatic brain injury (TBI) in a region of France, to compare this with recent recommendations from the French Society of Physical Medicine and Rehabilitation (SOFMER), and to evaluate associations between treatments and participant characteristics. SETTING: Outpatients referred to medical or community-based facilities in a region of France. PARTICIPANTS: One hundred twenty-nine adults with moderate to severe TBI, in the postacute period (over 3 months postinjury). <br><br>DESIGN: Cross-sectional cohort study. MAIN MEASURES: Sociodemographic data, ongoing interventions including psychotherapy and medication, behavioral disorders assessed by the Behavioral Dysexecutive Syndrome Inventory (BDSI). <br><br>RESULTS: Thirty-three percent of participants received ongoing psychotherapy and 43% were on medication. The most prescribed medications were antidepressants (21%), neuroleptics (18%), anxiolytics (16%), and mood stabilizers (14%). Eighty-five participants (71%) presented a current Behavioral Dysexecutive Syndrome (BDS) according to the BDSI. These participants more frequently received treatment (P =.004), psychotherapy (P =.048), medications (often 2 or more) (P =.007), and particularly antiepileptic mood stabilizers (P =.037) compared with those without BDS. <br><br>CONCLUSION: Although recommended as first-line treatment, few participants with BDS received psychotherapy. Medications were overused, especially neuroleptics in view of their potential adverse effects. In contrast, recommended medications, such as mood stabilizers and β-blockers, did not appear to be highly prescribed whatever the evolution. Compliance with recommendations seemed insufficient.<p /> <p>Language: en</p>",
language="en",
issn="0885-9701",
doi="10.1097/HTR.0000000000000452",
url="http://dx.doi.org/10.1097/HTR.0000000000000452"
}